BSEShelter Pharma LtdMediumPositive
Announced Tue, 5 May · 11:08 IST

Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Receipt of Significant International Purchase Orders.

Export Order Hard CurrencyBusiness Updates View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹30.38
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.0-1.2+10.9+6.0+4.7+4.1-0.8-4.5
Up moveDown movePending
AI summary

Shelter Pharma Limited has received repeat international purchase orders from its overseas customer, Taha Drugs & Chemicals Co. Ltd. The order includes D3 Cure Capsules (71,250 boxes worth USD 48,450) and Joemega Capsules (45,000 boxes worth USD 36,000), totaling USD 84,450. Payment terms are 50% advance at order placement and 50% against shipping bill. The company stated these repeat orders reflect continued customer trust and will enhance its global presence and business growth. The order is for nutraceutical products and will be executed within mutually agreed timelines.

Likely market impact

This is a positive development for shareholders as the company is gaining traction in international markets with repeat orders from existing customers. The USD-denominated order (hard currency) will benefit the company's foreign exchange earnings, though the absolute order size appears modest relative to typical pharmaceutical company revenues.